Who Owns Veradermics Stock?
NYSE: MANEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 98.43%
- Institutions (% of float)
- 100.94%
- Held by insiders
- 2.49%
- Institutional holders
- 229
- Institutions 97.5%
- Insiders 2.5%
- Public and other 0.0%
Who owns Veradermics stock?
Institutional investors own about 98.4% of Veradermics's shares, spread across 229 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.49% of MANE.
The largest institutional holders are Montanova Capital LLC (9.98%), FMR, LLC (7.67%) and SR One Capital Management, LP (5.75%). Together, the top 10 institutions control 49.6% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their MANE positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MANE
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Montanova Capital LLC | 4.17M | 9.98% | 0.0% |
| FMR, LLC | 3.20M | 7.67% | +78.8% |
| SR One Capital Management, LP | 2.40M | 5.75% | 0.0% |
| Deep Track Capital, Lp | 2.00M | 4.79% | +300.0% |
| Citadel Advisors Llc | 1.88M | 4.49% | +2.9% |
| Siren, L.L.C. | 1.66M | 3.96% | +10.0% |
| Blackrock Inc. | 1.59M | 3.81% | +463.9% |
| Viking Global Investors, L.P. | 1.56M | 3.74% | -7.6% |
| JPMORGAN CHASE & CO | 1.17M | 2.79% | +19.4% |
| Aberdeen Group plc | 1.10M | 2.62% | +4.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MANE
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 771.42K | 1.85% |
| abrdn Healthcare Investors | 627.84K | 1.50% |
| abrdn Healthcare Opportunities Fund | 626.98K | 1.50% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 618.42K | 1.48% |
| iShares Trust-iShares Russell 2000 ETF | 555.08K | 1.33% |
| abrdn World Healthcare Fund | 341.88K | 0.82% |
| J.P. Morgan Mutual Fd. Investment TRT-JPMorgan Growth Advantage Fd. | 320.60K | 0.77% |
| abrdn Life Sciences Investors | 280.69K | 0.67% |
| JPMorgan Trust II-JPMorgan Small Cap Growth Fund | 263.85K | 0.63% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 238.10K | 0.57% |
Frequently asked questions
Who is the largest shareholder of Veradermics?
Montanova Capital LLC is the largest institutional shareholder of MANE, owning 9.98% of shares outstanding (4.17M shares) as of its latest 13F filing.
What percentage of Veradermics is owned by institutions?
Institutions own about 98.4% of MANE shares and 100.9% of the public float.
How much of Veradermics do insiders own?
Insiders, such as officers and directors, own about 2.49% of MANE shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.